Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 781
Filter
1.
Acta Medica Iranica ; 60(6):329-337, 2022.
Article in English | EMBASE | ID: covidwho-2033504

ABSTRACT

Solid-organ transplantation recipients were assumed highly vulnerable to coronavirus disease 2019 (COVID-19). However, the results of previous studies in patients with orthotopic heart transplantation (OHT) under immunosuppressive therapy are contradictory. Therefore, we aimed to assess the prevalence of COVID-19 infection and associated risk factors, along with the six-month outcomes in COVID-19 positive OHT patients. This single-center telephone-based survey was conducted on OHT patients. Using a detailed questionnaire, exposure to COVID-19, related symptoms, and preventive self-care measures were collected. Outcomes of COVID-19-positive patients were reassessed using another survey six months later. 118 OHT patients (male: n=87, 73.7%) were included with a mean age of 45.3±13.1 years. Sixteen patients (13.5%) reported one or more symptoms compatible with COVID-19, of whom 12 (10.2%) tested positive. Our results indicated no statistically significant association between COVID-19 and comorbidities. Poor adherence to self-care measures and contact with positive index cases were both significantly associated with COVID-19 infection (P<0.001). A later six months follow-up showed that two out of 12 (16.6%) COVID-19 positive OHT patients died. There was no statistically significant difference between the prevalence of COVID-19 in our patients compared to Iran’s general population (P=251.0). Non-compliance with personal protective protocols and a history of contact with COVID-19 cases were the most risk factors for COVID-19 infection in OHT patients.

2.
Journal of Clinical and Diagnostic Research ; 16(9):XD01-XD03, 2022.
Article in English | EMBASE | ID: covidwho-2033408

ABSTRACT

Chronic lymphocytic leukaemia is a haematological malignancy that occurs due to an increased proliferation of mature B lymphocytes. It is considered to be the most common leukaemia in adults. Hyponatremia is commonly seen in such patients. This case report is about a 75-year-old male, who presented with giddiness, followed by altered sensorium. However, the patient had no motor weakness or sensory loss. Initially, a diagnosis of posterior circulation stroke was made but Magnetic Resonance Imaging (MRI) brain did not show associated signs. The routine investigations showed highly elevated total leukocyte count and hyponatremia. The patient was worked up for malignancy and diagnosed with Chronic lymphocytic leukaemia. Oncology reference was taken and treated with tablet Ibrutinib. On discharge, the patient's mentation improved, and he is on regular follow-up.

3.
ASAIO Journal ; 68:83, 2022.
Article in English | EMBASE | ID: covidwho-2032188

ABSTRACT

Purpose: Percutaneous cannulation for Veno-Venous (V-V) and Veno-Pulmonary Arterial (V-PA) ECMO has transformed our approach to extracorporeal support, particularly in the Covid-19 era. Along with the increase in percutaneous cannulation comes an increase in complications, some necessitating replacement of the cannula. We present a novel technique to exchange cannulas using the same site with minimal blood loss and time off support. Method: All procedures were performed in the hybrid OR with fluoroscopy and transesophageal echocardiography (TEE). A 4 Fr. dilator was placed posteromedial to the existing cannula with pressure directed toward the cannula to enter the vein. A wire was placed through the dilator to facilitate directing the wire into the PA or IVC, ultimately advancing the wire into the RPA (V-PA) or IVC (V-V). The ECMO circuit was clamped and both limbs transected. The existing cannula was removed simultaneously with the new cannula being placed over the wire into either PA or IVC (V-PA or V-V respectively). The cannula was deaired, reconnected to the ECMO circuit, and flow reestablished. Results: 8.1% (19/234) of our V-V or V-PA patients required replacement of the percutaneous cannula. 63% were due to RV failure diagnosed by echocardiography and 32% were for cannula migration below the pulmonary valve into the RV. Our technique was universally successful with a mean blood loss of 20cc, <1.5 minutes off ECMO, and no complications. Summary: The described technique is effective in replacing percutaneous V-V and V-PA ECMO cannulas using the original site with minimal time off support and blood loss. (Figure Presented).

4.
ASAIO Journal ; 68:76, 2022.
Article in English | EMBASE | ID: covidwho-2032187

ABSTRACT

Purpose: Multisystem inflammatory syndrome in children (MIS-C) is a rare but life-threatening complication of SARS-CoV-2 that is characterized by a hyperinflammatory state leading to multiorgan dysfunction. With prompt initiation of appropriate medical management, patients fair well with resolution of the hyperinflammatory state and recovery of end-organ function. However, a small subset of patients with MIS-C develop progressive end-organ dysfunction necessitating mechanical circulatory support (MCS). This case series describes a single center experience of MCS for MIS-C. Methods: This is a retrospective case series of patients diagnosed with MIS-C who required MCS between May 2020-February 2022 at Texas Children's Hospital. The study was conducted under institutional review board approval. Results: During the study period, 291 patients were diagnosed with MISC. Of those, 6 required MCS: 4 were placed on VAECMO with 1 patient additionally requiring a left ventricular assist device (LVAD), 1 required solely LVAD support, and 1 required VV-ECMO in the setting of pulmonary hemorrhage. In 5 of the 6 patients, the primary indication for MCS was a hemodynamically significant tachyarrythmia. Echocardiography showed worsening of global longitudinal strain (GLS) prior to cannulation in those patients in which it was measured. 5 of the 6 patients survived to hospital discharge. 2 patients required emergent fasciotomies and subsequent limb amputation. Immunomodulation with anakinra before MCS correlated with shorter intensive care length of stay. Outpatient follow-up was conducted in the MIS-C clinic, ranging from 1 to 15 months since discharge, with notable normalization of cardiac function and no additional adverse events. Conclusion: Overall, the need for MCS in patients diagnosed with MIS-C is uncommon and outcomes seem favorable. The development of tachyarrhythmias and worsening GLS may be risk factors for MCS. These findings need to be validated with larger, multicenter studies. Prospective studies of early therapeutic intervention in MIS-C are also needed.

5.
JACC: Case Reports ; 4(16):1026-1031, 2022.
Article in English | EMBASE | ID: covidwho-2031404

ABSTRACT

The authors present a very rare case of bacterial purulent pericarditis due to Actinomyces odontolyticus 2 weeks following an endobronchial ultrasound bronchoscopy. On his presentation, he was in cardiac tamponade, for which he underwent an emergent pericardiocentesis with purulent drainage. Similar organisms grew in his left pleural effusion. (Level of Difficulty: Intermediate.)

6.
IDCases ; 30, 2022.
Article in English | EMBASE | ID: covidwho-2031315

ABSTRACT

Brevibacterium species are to be opportunistic pathogens. Although rare, several case reports have mentioned infections ranging from cutaneous infections to bacteremia. Here, we present a case report describing a 64-year-old male pancreatic cancer patient diagnosed with B. luteolum bacteremia.

7.
Current Problems in Cardiology ; : 101396, 2022.
Article in English | ScienceDirect | ID: covidwho-2031224

ABSTRACT

Introduction In the COVID-19 pandemic, to minimize aerosol-generating procedures, cardiac magnetic resonance imaging (CMR) was utilized at our institution as an alternative to transesophageal echocardiography (TEE) for diagnosing infective endocarditis (IE). Methods This retrospective study evaluated the clinical utility of CMR for detecting IE among 14 patients growing typical microorganisms on blood cultures or meeting modified Duke criteria. Results 7 cases were treated for IE. In 2 cases, CMR results were notable for possible leaflet vegetations and were clinically meaningful in guiding antibiotic therapy, obtaining further imaging, and/or pursuing surgical intervention. In 2 cases, vegetations were missed on CMR but detected on TEE. In 3 cases, CMR was nondiagnostic, but patients were treated empirically. There was no difference in antibiotic duration or outcomes over 1 year. Conclusion CMR demonstrated mixed results in diagnosing valvular vegetations and guiding clinical decision making. Further prospective controlled trials of CMR vs TEE are warranted.

8.
Egyptian Journal of Hospital Medicine ; 88(1):3959-3968, 2022.
Article in English | Scopus | ID: covidwho-2026194

ABSTRACT

Background: Myocardial injury is neither limited to the acute Coronavirus disease 2019 nor moderate-to-severe cases. Objectives: This study aimed to evaluate the relationship between right ventricular diastolic dysfunction and post-Coronavirus disease 2019 cardiovascular sequelae in young adults with mild disease. Patients and Methods: This study recruited 150 young adults (between 18 and 30 years) who were classified into three equal groups: Group A included 50 patients who sustained cardiac symptoms 12 to 14 weeks following mild Coronavirus disease 2019. Group B included 50 patients who did not show cardiac symptoms 12 to 14 weeks following mild Coronavirus disease 2019. Group C included 50 gender-matched healthy subjects of similar ages without previous Coronavirus disease 2019. Each subject underwent a detailed transthoracic echocardiographic study to detect right ventricular diastolic dysfunction by measuring the tricuspid valve E/A ratio, tricuspid deceleration time, tricuspid E/e' ratio and tricuspid e'/a' ratio. Results: Right ventricular diastolic dysfunction was higher in group A (80% versus 30% versus 0%, p < 0.001). Tricuspid valve e’/a’ was lower in group A (0.86 ± 0.2 versus 1.08 ± 0.2 versus 1.44 ± 0.28, p < 0.001) while tricuspid valve E/ e’ was higher (6.7 ± 1.1 versus 3.25 ± 3 versus 3.04 ± 0.36, p < 0.001). Post-Coronavirus disease 2019 patients with right ventricular diastolic dysfunction had a higher right ventricular basal diameter, higher right ventricular systolic pressure, lower right ventricular tricuspid annular plane systolic excursion, and lower fractional area change. Conclusions: After recovery from mild Coronavirus disease 2019, some of young adults had right ventricular diastolic dysfunction, which was more prevalent in those with post-Coronavirus disease 2019 cardiac symptoms. © 2022, Ain Shams University Faculty of Medicine. All rights reserved.

9.
Journal of Cardiovascular Echography ; 32(2):107-111, 2022.
Article in English | Web of Science | ID: covidwho-2024736

ABSTRACT

Background: The Severe acute respiratory syndrome coronavirus 2, is the pathogen that causes COVID-19. Cardiovascular (CV) involvement during this infection, has been related to adverse outcomes. Interestingly, some patients may remain symptomatic beyond the first 14 days of disease diagnosis. Although a particular reduction on left ventricular (LV) global longitudinal strain (GLS) in basal segments has been recently described in patients hospitalized with diagnosis of COVID-19, the correlation of these findings with the persistence of symptoms has not been determined. Objectives: The objective of this study is to describe echocardiographic findings in patients recovered from COVID-19 and to determine its association with persistent dyspnea. Methods: Seventy-six patients were analyzed. Forty-six were asymptomatic (group N & DEG;1) and 30 referred persistent dyspnea at the time of examination (group N & DEG;2), and a cohort of 25 healthy individuals was included as a control group. Total LV GLS, average basal LV GLS, and average mid-apical LV GLS were assessed. Basal-mid-apical index (BMAI) was calculated. A difference in BMAI bigger than 15% between both groups was stablished as cutoff point. Results: Nonsignificative differences on standard echocardiographic measurements were found between the analyzed groups. When compared to the control group, there was nonsignificative reduction on basal LV GLS values in patients with persistent dyspnea. However, BMAI values were bigger than 15% in 70% of patients from group N & DEG;2 but in none of the patients from the control group (P = 0.0002). Conclusions: This new index allowed to identify an abnormal relation in LV GLS values between basal and medium-apical segments among patients recovered from COVID-19 and persistent dyspnea.

10.
J Cardiovasc Dev Dis ; 9(8)2022 Jul 25.
Article in English | MEDLINE | ID: covidwho-2023766

ABSTRACT

Nine ski mountaineering (Ski-Mo), ten Nordic-cross country (NCC), and twelve world elite biathlon (Bia) athletes were evaluated for cardiopulmonary exercise test (CPET) performance and pronounced echocardiographic physiological cardiac remodeling as a primary aim of our descriptive preliminary report. In this context, a multicenter retrospective analysis of two-dimensional echocardiographic data including speckle tracking of the left ventricle (LV-GLS) and CPET performance analysis was performed in 31 elite world winter sports athletes, which were obtained during the annual sports medicine examination between 2020 and 2021. The matched data of the elite winter sports athletes (14 women, 17 male athletes, age: 18-32 years) were compared for different CPET and echocardiographic parameters, anthropometric data, and sport-specific training schedules. Significant differences could be revealed for left atrial (LA) remodeling by LA volume index (LAVI, p = 0.0052), LV-GLS (p = 0.0003), and LV mass index (LV Mass index, p = 0.0078) between the participating disciplines. All participating athletes showed excellent performance data in the CPET analyses, whereby significant differences were revealed for highest maximum respiratory minute volume (VE maximum) and the maximum oxygen pulse level across the participating athletes. This study on sport specific physiological demands in elite winter sport athletes provides new evidence that significant differences in CPET and cardiac remodeling of the left heart can be identified based on the individual athlete's training schedule, frequency, and physique.

11.
International Journal of Environmental Research and Public Health ; 19(16):10038, 2022.
Article in English | ProQuest Central | ID: covidwho-2023647

ABSTRACT

Mild left ventricular hypertrophy (LVH) has been considered as one of the possible structural, physiological adaptations to regular, intensive physical activity. However, it may also appear as one of the subclinical complications of hypertension. In athletes, the differential diagnosis between these two entities may be complicated as regular physical activity may potentially mask the presence of arterial hypertension. We sought to determine the relation between LVH in middle-age athletes and the presence of hypertension. The study included 71 healthy, male long-time amateur athletes (mean age 41 ± 6 years, 83% endurance and 17% power sports) without known hypertension or any other cardiovascular diseases and with normal self-measured and office blood pressure. All subjects underwent resting electrocardiogram, transthoracic echocardiography, maximal exercise test on a treadmill and ambulatory blood pressure monitoring. LVH was diagnosed as left ventricular wall diameter >11 mm. Hypertension was defined as mean 24 h systolic blood pressure (SBP) ≥ 130 mmHg and/or diastolic blood pressure (DBP) ≥ 80 mmHg. Exaggerated blood pressure response (EBPR) to exercise was defined as SBP ≥ 210 mmHg. LVH (range > 11 to 14 mm) was found in 20 subjects (28%) and hypertension was diagnosed in 33 subjects (46%). Athletes with LVH were more likely to have hypertension than those without LVH (70% vs. 37%, p = 0.01). EBPR to exercise was found equally common in athletes with and without LVH (35% vs. 29%, p = 0.68), but more often in subjects with hypertension (51% vs. 13%, p < 0.001). Presence of LVH and hypertension was equally common in the studied endurance and power sport athletes (p = 0.66 and p = 0.79, respectively). In comparison to athletes without LVH, those with LVH had larger left atrial size (26 ± 6 vs. 21 ± 4 cm2, p < 0.001) and a tendency for lower left ventricular diastolic function (E/A 1.2 ± 0.4 vs. 1.5 ± 0.4, p = 0.05) and a larger ascending aorta diameter (34 ± 3 vs. 32 ± 3, p = 0.05), but a similar left ventricular end-diastolic diameter (51 ± 3 vs. 51 ± 4, p = 0.71). The presence of mild left ventricular hypertrophy in middle-age male amateur athletes with normal home and office blood pressure may be considered as a potential sign of masked hypertension. It should not be overlooked as an element of a physiological adaptation to exercise and may warrant further medical evaluation with ambulatory blood pressure monitoring.

12.
Cells ; 11(16):2614, 2022.
Article in English | ProQuest Central | ID: covidwho-2023200

ABSTRACT

Obesity is of concern to the population because it is known to cause inflammation and oxidative stress throughout the body, leading to patient predisposition for health conditions such as diabetes, hypertension, and some cancers. However, some proteins that are activated in times of oxidative stress may provide cytoprotective properties. In this study, we aim to gain further understanding of the interconnection between Nrf2 and Sesn2 during obesity-related stress and how this relationship can play a role in cardio-protection. Cardiomyocyte-specific Sesn2 knockout (cSesn2−/−) and Sesn2 overexpressed (tTa-tet-Sesn2) mice and their wildtype littermates (Sesn2flox/flox and tet-Sesn2, respectively) were assigned to either a normal chow (NC) or a high-fat (HF) diet to induce obesity. After 16 weeks of dietary intervention, heart function was evaluated via echocardiography and cardiac tissue was collected for analysis. Immunoblotting, histology, and ROS staining were completed. Human heart samples were obtained via the LifeLink Foundation and were also subjected to analysis. Overall, these results indicated that the overexpression of Sesn2 appears to have cardio-protective effects on the obese heart through the reduction of ROS and fibrosis present in the tissues and in cardiac function. These results were consistent for both mouse and human heart samples. In human samples, there was an increase in Sesn2 and Nrf2 expression in the obese patients’ LV tissue. However, there was no observable pattern of Sesn2/Nrf2 expression in mouse LV tissue samples. Further investigation into the link between the Sesn2/Nrf2 pathway and obesity-related oxidative stress is needed.

13.
Annals of Intensive Care ; 12(1), 2022.
Article in English | Web of Science | ID: covidwho-2021335
14.
BMJ Open ; 12(9), 2022.
Article in English | ProQuest Central | ID: covidwho-2020030

ABSTRACT

IntroductionGiven that exercise training reduces the risk of developing Alzheimer’s disease (AD), induces changes in the blood composition and has widespread systemic benefits, it is reasonable to hypothesise that exercised plasma (ExPlas) may have rejuvenative properties. The main objective is to test safety and tolerability of transfusing ExPlas from young, healthy, fit adults to patients with mild cognitive impairment (MCI) or early AD. The study is a pilot for a future efficacy study. The key secondary objectives are examining the effect of plasma transfusions on cognitive function, fitness level, vascular risk profile, assessment of cerebral blood flow and hippocampal volume, quality of life, functional connectivity assessed by resting state functional MRI and biomarkers in blood and cerebrospinal fluid.Methods and analysisExPlas is a double-blinded, randomised controlled clinical single-centre trial. Patients up to 75 years of age with diagnosis early symptomatic phase AD will be recruited from two Norwegian hospitals. ExPlas is plasma drawn by plasmapheresis once a month for 4 months, from a total of 30 fit male donors (aged 18–40, BMI≤27 kg/m2 and maximal oxygen uptake>55 mL/kg/min). All units will be virus inactivated by the Intercept method in accordance with procedures at St. Olavs University Hospital. Comparison with isotonic saline allows differentiation from a non-blood product. The main study consists of 6 rounds of examinations in addition to 12 plasma transfusions divided over three 4-week periods during study year-1. It is also planned to conduct follow-up examinations 2 and 5 years after baselineEthics and disseminationWritten informed consent will be obtained from all participants and participation is voluntary. All participants have a next of kin who will follow them throughout the study to represent the patient’s interest. The study is approved by the Regional Committee for Medical and Health Research Ethics (REK 2018/702) and the Norwegian Medicines Agency (EudraCT No. 2018-000148-24). The study will be published in an open access journal and results will be presented at numerous national and international meetings as well as on social media platforms.Trial registration numberEudraCT No. 2018-000148-24. ClinicalTrials.gov, NCT05068830

15.
Archives of Disease in Childhood ; 107(Suppl 2):A425-A426, 2022.
Article in English | ProQuest Central | ID: covidwho-2019922

ABSTRACT

AimsThe COVID-19 pandemic necessitated remote consultation for outpatient referrals in many hospitals in the UK and encouraging results have been recorded from adult studies. There is a limited evidence base for telephonic consultation in paediatric cardiology patients, which is even more complicated by the perceived need for echocardiography. This brief report evaluates patients assessed over the telephone in a single paediatric cardiology outpatient clinic over a 15-month period.MethodsData (demographics, clinical information, and outcomes) on new referrals to a single paediatric cardiology clinic between March 2020 and May 2021 was analysed retrospectively. These patients had been initially assessed telephonically and subsequently face-to-face. We excluded patients who already had a cardiac diagnosis or were seen face-to-face on an earlier occasion. In addition, a survey was sent to parents or carers of patients, and another was sent to young patients aged >12 years, to ascertain what they thought about the approach in the context of the pandemic.ResultsOut of 93 new patients assessed telephonically, 64 were subsequently assessed face-to-face and were included in the data analysis. 34 of these patients were male and 30 were female, ranging in age from four days to 15 years old. Reasons for referral included cardiac-related symptoms (17%), an asymptomatic finding (53%) such as a heart murmur, and a requirement for screening (30%). After the initial appointment, 18 patients (28%) assessed to have possible significant heart disease were scheduled for a face-to-face appointment within 3 months, 28 (44%) assessed to have possible minor heart disease were scheduled within 6 months, and 18 (28%) assessed to have probable normal hearts were scheduled within 1 year. Outcomes from face-to-face consultation were either: reassurance and discharge (51%), remaining within the clinic for long-term follow-up (44%), or referral for intervention on an elective timescale (5%).Results from the surveys are encouraging so far in terms of acceptability of telephone consultation in the context of a pandemic. All results have not yet been recorded;hence they cannot be fully analysed at this time.ConclusionThe data collected from this sample of patients supports the safety of telephone consultation for initial assessment in outpatient paediatric cardiology during a pandemic. It also supports the extrapolation of results to a period when normalcy is established.

16.
Archives of Disease in Childhood ; 107(Suppl 2):A361-A362, 2022.
Article in English | ProQuest Central | ID: covidwho-2019900

ABSTRACT

656 Table 1Demographics and outcome of referral 656 Table 2Investigations for PIMS-TS documented at referral27 (66%) children had abdominal symptoms at the time of referral. Of these 9 (33%) received abdominal imaging, 12 (44%) had no imaging, and in 6 (22%) the transport service recommended imaging. 29 (71%) of children were cardiovascularly unstable at the time of referral, of which 6 (21%) had received an echocardiogram, 18 (62%) had not received an echocardiogram, and in 5 (17%) the transport service recommended an echocardiogram.22 (54%) of referrals included tertiary specialities in the conference call;most commonly rheumatology (20 referrals, 49%). 13 children (32%) had already been discussed at the daily regional PIMS-TS MDT, 1 child (2%) was recommended to be discussed with the MDT, and the 27 (66%) were not discussed.ConclusionThe majority of children referred to the regional transport service did receive the recommended investigations or involvement of the MDT. To improve documentation and advice given to the referring teams a proforma has been created for all children referred to the transport service with suspected PIMS-TS.ReferenceA national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process. PIMS-TS National Consensus Management Study Group;Lancet Child Adolesc Health 2021;5: 133–41.

17.
ESC Heart Fail ; 2022.
Article in English | Web of Science | ID: covidwho-2013463

ABSTRACT

Multisystem Inflammatory Syndrome in Adult (MIS-A) is a rare COVID-19 complication, presenting as fever with laboratory evidence of inflammation, severe illness requiring hospitalization and multisystem organ involvement. We report on a 25-year-old man presenting with fever, rash, abdominal pain, diarrhoea and vomiting following prior asymptomatic COVID-19 infection. He developed refractory shock and type 1 respiratory insufficiency requiring mechanical ventilation. Diagnostic testing revealed significant inflammation, anemia, thrombocytopenia, acute kidney injury, hepatosplenomegaly, colitis, lymphadenopathy and myocarditis necessitating inotropy. Ventilatory, vasopressor and inotropic support was weaned following pulse corticosteroids and intravenous immunoglobulins. Heart failure therapy was started. Short-term follow-up shows resolution of inflammation and cardiac dysfunction.

18.
Annals of Intensive Care ; 12(1), 2022.
Article in English | EMBASE | ID: covidwho-2009462
19.
Annals of the Rheumatic Diseases ; 81:1667, 2022.
Article in English | EMBASE | ID: covidwho-2008852

ABSTRACT

Background: It has been more than a year and a half since the WHO announced a pandemic of a new coronavirus infection caused by SARS-CoV-2. The virus belongs to the respiratory group, but it it can damage various organs and tissues of the body. COVID-19 infection is characterized by pathological activation of immunity, violated synthesis of pro-infammatory, immunoregulatory, anti-infammatory cytokines, such as interleukins-1 and-6, tumor necrosis factor α and others. These features contribute to the development of rheumatic diseases and syndromes in people who have had COVID-19. Cellular and humoral immune responses are also of primary importance in the pathogenesis of infammatory myopathies. Objectives: Description of a case of severe dermatomyositis after COVID-19. Methods: The 34-year-old female patient complained of pain and weakness in the proximal muscles of the upper and lower extremities, difficulty swallowing solid and liquid food, rash on the face, neck, chest and arms. In August 2020 she had a mild case of COVID-19. A month later, faky erythematous papules like Gottron's sign appeared on the extensor surfaces of the metacarpophalangeal joints and proximal interphalangeal joints of the hands. Six months later, sore throats, hoarseness of voice, belching of air, choking on solid food and episodes of subfebrility joined. Refux esophagitis, duodenitis was detected by fbrogastroduodenoscopy. After 9 months, there were muscle pains and muscle weakness, erythema on the face, neck and chest, the patient lost 11 kg. She was hospitalized in the rheumatology department with suspected dermatomyositis. Results: On objective examination: proximal myopathy, erythematous rashes on the face, neck, chest, Gottron's erythema on the hands. In the analyses: clinical analysis of blood and urine without pathology, ANA 1:1280, creatinkinase 5370 IU/l, with an increase in dynamics up to 9260 IU/l, CRP 0.03 mg/dl, LDH 1023 IU/l, rheumatoid factor and anti-ds DNA were negative. Nasal regurgitation was detected during radiography of the pharynx with contrast. Instrumental examination revealed no signs of a tumor process. Fibrogastroduodenoscopy-superfcial refux-esophagitis, duodenitis, Chest CT-interstitial pneumonitis, abdominal ultrasound without pathology, ECG-sinus rhythm, normal EOS position, accelerated A-V conduction, echocardiography-minor separation of pericardial leaves (up to 5 mm), colonoscopy-dolichosigma. The patient was diagnosed with idiopathic dermatomyositis of high activity. Because of progressive myopathy and increasing dysphagia, pulse therapy with methylpredniso-lone500 mg for 3 days and rituximab 1000 mg was performed. She also received metipred 48 mg per day orally, methotrexate 15 mg per week subcutaneously and folic acid 5 mg per week. Against the background of therapy, positive dynamics was noted: swallowing normalized, the severity of myopathy decreased, after 10 days CKdecreased to 2049 IU/l. After 6 months during the control examination: there are no skin rashes, muscle strength is restored, CK 300 IU/l. The dose of methylprednisolone is reduced to 10 mg per day, the patient continues injections of methotrexate 15 mg per week. Conclusion: COVID-19 may be a trigger for the development of infammatory myopathy. In this clinical case there are features of the course and therapy of infammatory myopathies in patients after coronavirus infection.

20.
Journal of Neuroimaging ; 32(4):770-771, 2022.
Article in English | EMBASE | ID: covidwho-2008751

ABSTRACT

Background and Purpose: Since the implementation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, we see continued hesitancy across the world regarding the potential emergence of immune and thromboembolic complications with these injections. This has included temporary pauses over concerns for thromboembolic events and cardiac inflammation.We provide discussion of a 57-year-old patient who suffered multiple ischemic strokes, with no prior history of vascular events after receiving her SARSCoV- 2 (messenger ribonucleic acid [mRNA]) vaccination with workup suggesting CNS vasculitis in the setting of multiple positive immune markers and propose the need for further investigation in this area. Methods:Review of case presentation, testing, imaging, and laboratory studies. Results: CT angiography was performed but could not identify any vascular pathology in the large vasculature. Brain MRI/MR angiography demonstrated strokes in multiple vascular territories (similar findings on first and second admission). Conventional angiogram was completed, which also did not demonstrate large vessel abnormalities. Telemetry was unremarkable. Echocardiogram (transthoracic and transesophageal) was performed without cardioembolic source identified. Serum and CSF laboratory studies were completed and suggestive of a CNS immune process and given the overall clinical picture were most consistent with probable small vessel CNS vasculitis. Conclusion: In presenting this patient's background and medical history, which includes autoimmune hepatitis, we propose there may be a subpopulation who could be at higher risk of immune reactions in the setting of these vaccinations and that while generally still safe for the overall population, in these particular subpopulations increased caution may be warranted pending further investigation, particularly if considering the newermRNA vaccinations.

SELECTION OF CITATIONS
SEARCH DETAIL